F. Akyol Et Al. , "Biochemical response to neoadjuvant hormonoterapy may predict biochemical control rate and distant metastasis free survival after total short term androgen deprivation and conformal radiotherapy in the treatment of prostate adenocarcinoma," EJC SUPPLEMENTS , vol.3, no.2, pp.248, 2005
Akyol, F. Et Al. 2005. Biochemical response to neoadjuvant hormonoterapy may predict biochemical control rate and distant metastasis free survival after total short term androgen deprivation and conformal radiotherapy in the treatment of prostate adenocarcinoma. EJC SUPPLEMENTS , vol.3, no.2 , 248.
Akyol, F., Ozyigit, G., Selek, U., Onal, C., Karabulut, E., & Ozen, H., (2005). Biochemical response to neoadjuvant hormonoterapy may predict biochemical control rate and distant metastasis free survival after total short term androgen deprivation and conformal radiotherapy in the treatment of prostate adenocarcinoma. EJC SUPPLEMENTS , vol.3, no.2, 248.
Akyol, F. Et Al. "Biochemical response to neoadjuvant hormonoterapy may predict biochemical control rate and distant metastasis free survival after total short term androgen deprivation and conformal radiotherapy in the treatment of prostate adenocarcinoma," EJC SUPPLEMENTS , vol.3, no.2, 248, 2005
Akyol, F. Et Al. "Biochemical response to neoadjuvant hormonoterapy may predict biochemical control rate and distant metastasis free survival after total short term androgen deprivation and conformal radiotherapy in the treatment of prostate adenocarcinoma." EJC SUPPLEMENTS , vol.3, no.2, pp.248, 2005
Akyol, F. Et Al. (2005) . "Biochemical response to neoadjuvant hormonoterapy may predict biochemical control rate and distant metastasis free survival after total short term androgen deprivation and conformal radiotherapy in the treatment of prostate adenocarcinoma." EJC SUPPLEMENTS , vol.3, no.2, p.248.
@article{article, author={F. Akyol Et Al. }, title={Biochemical response to neoadjuvant hormonoterapy may predict biochemical control rate and distant metastasis free survival after total short term androgen deprivation and conformal radiotherapy in the treatment of prostate adenocarcinoma}, journal={EJC SUPPLEMENTS}, year=2005, pages={248} }